Nifty  20901.15  -36.55  (-0.17%)

Sensex  69521.69  -132.04  (-0.19%)

USDINR  83.38  0.03  (0.04%)

RIL, SBI, Bajaj Finance, Delta Corp in focus
(08:35, 25 Sep 2023)

Reliance Industries (RIL): Reliance Retail Ventures received the subscription amount of Rs 2,069.50 crore from Alyssum Asia Holdings II Pte. Ltd. (KKR) and allotted 1,71,58,752 equity shares to KKR.

SBI: The country's largest lender said that it has raised Rs 10,000 crore through its fourth infrastructure bond on 22 September 2023, at coupon rate of 7.49%. The proceeds of bonds will be utilized in enhancing long term resources for funding infrastructure and affordable housing segment.

Bajaj Finance: Bajaj Finance said that its board will meet on Thursday, 5 October 2023, to consider a proposal for fund raising. The firm will raise funds through any or all of various methods including by way of preferential issue, qualified institutions placement.

Delta Corp: The company and/or its subsidiaries have received intimations for payment of shortfall tax under Section 74(5) of the CGST Act, 2017 and Goa SGST Act, 2017, for the period from July 2017 to March 2022, from the Directorate General of GST Intelligence, Hyderabad.

Vaibhav Global: Shop TJC Ltd (UK), a wholly owned subsidiary of Vaibhav Global, announced that it has successfully executed an Asset Sale Agreement to acquire assets of Ideal World Ltd. Ideal World is one of the major teleshopping brands in the UK.

Strides Pharma Science: Strides Pharma Science said that its wholly owned subsidiary, Strides Pharma Global, Singapore has received US Food and Drug Administration (USFDA) approval for Icosapent Ethyl Capsules 0.5 gram and 1 gram.

Powered by Capital Market - Live News